|March 9, 2017||
The Colonnade Hotel
120 Huntington Avenue
Boston, MA 02116
Starting at $1950
BD Boston brings together leading life science decision makers, entrepreneurs, venture capitalists, buysiders, corporate venture, and investors for an off-the-record and interactive forum on the market and deal-making opportunities. Dynamic panels and networking take center stage.
Speakers include: Richard Brudnick, SVP, Corporate Development, Biogen; Hugh Cole, CBO, ARIAD; Mike Crowley, Global Head Innovation Partnering, Roche; Rosamond Deegan, CBO, Bicycle Therapeutics; Doug Giordano, SVP, Worldwide BD, Pfizer; Philippe Lopes-Fernandes, SVP, Global Head of BD & Alliance Management, EMD Serono; Ivana Magovcevic-Liebisch, SVP and Head of Global BD, Teva; Anna Maroney, VP, Head of Alliance Management, AbbVie; Kia Motesharei, VP, Global Head of BD, Neurology, & Immunology, EMD Serono; Bob Oliver, President & CEO, Otsuka Pharmaceuticals; Dan Paterson, COO, Verastem; Sanjiv Patel, EVP, Chief Strategy Officer, Allergan; Joe Payne, President & CEO, Arcturus; Michal Preminger, Executive Director, Harvard University; Jigar Raythata, CBO, Jounce Therapeutics; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Catherine Sohn, Chairman, ConcentRx, Inc.; Pascal Touchon, Global Head Oncology Strategy & BD, Novartis; Chris Viehbacher, Managing Partner, Gurnet Point Capital; James Zanewicz, CBO, Research, Tulane University
Premier Sponsors: (see all sponsors)